TWD 86.8
(1.05%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Operating Cash Flow | 525.46 Million | 594.02 Million | -122.96 Million | 482.79 Million | - |
Net Income | 627.31 Million | 547.08 Million | 250.88 Million | 202.12 Million | - |
Depreciation & Amortization | 59.31 Million | 57.1 Million | 54.8 Million | 38.37 Million | - |
Deferred income taxes | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - |
Change in working capital | -62.19 Million | 3.89 Million | -400.89 Million | 282.63 Million | - |
Other non-cash items | -13.23 Million | 16.72 Million | 12.23 Million | 3.25 Million | - |
Investing Cash Flow | -190.96 Million | -237.39 Million | -30.17 Million | -443.99 Million | - |
Investments in PPE | -56.97 Million | -17.47 Million | -22.11 Million | -104.33 Million | - |
Acquisitions | - | -13.36 Million | -17.03 Million | - | - |
Investment purchases | -393.65 Million | -445.17 Million | -479.69 Million | -438.55 Million | - |
Sales/Maturities of investments | 401.86 Million | 461.43 Million | 489.08 Million | 430.97 Million | - |
Other Investing Activities | -6.86 Million | 102 Thousand | -498 Thousand | 701 Thousand | - |
Financing Cash Flow | 86.76 Million | 181.66 Million | 48.87 Million | -91.58 Million | - |
Debt repayment | -341.4 Million | -200.59 Million | -147.44 Million | -85.18 Million | - |
Dividends payments | -260.4 Million | -130.2 Million | -104.16 Million | -104.16 Million | - |
Common Stock Repurchased | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - |
Other Financing Activities | 5.77 Million | 111.26 Million | 5.59 Million | -71.37 Million | - |
Accounts receivables | -100.71 Million | - | - | - | - |
Accounts payables | 33.5 Million | - | - | - | - |
Inventory | -7.12 Million | -9.03 Million | -2.16 Million | 1.53 Million | - |
Other working capital | 45.64 Million | - | - | - | - |
Cash at beginning of period | 1.3 Billion | 769.63 Million | 872.29 Million | 924.3 Million | - |
Cash at end of period | 1.71 Billion | 1.3 Billion | 769.63 Million | 872.29 Million | - |
Capital Expenditure | -56.97 Million | -17.47 Million | -22.11 Million | -104.33 Million | - |
Effect of forex changes on cash | -2.03 Million | -7.87 Million | 1.6 Million | 765 Thousand | - |
Net cash flow / Change in cash | 419.22 Million | 530.41 Million | -102.66 Million | -52.01 Million | - |
Free Cash Flow | 468.48 Million | 576.54 Million | -145.07 Million | 378.46 Million | - |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 192.58 Million | 180.87 Million | 627.31 Million | 127.91 Million | 213.01 Million | 214.19 Million |
Depreciation & Amortization | 16.51 Million | 15.77 Million | 59.31 Million | 15.39 Million | 14.7 Million | 14.74 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -3.59 Million | -23.41 Million | -62.19 Million | -34.28 Million | -19.16 Million | -59.82 Million |
Other non-cash items | -10.36 Million | -8.04 Million | -13.23 Million | -6.99 Million | -2.85 Million | -3.83 Million |
Investing Cash Flow | -41.94 Million | -57.61 Million | -190.96 Million | 41.83 Million | -101.45 Million | -58.21 Million |
Investments in PPE | -14.21 Million | -28.33 Million | -56.97 Million | -22.26 Million | -11.6 Million | -5.19 Million |
Acquisitions | - | - | - | - | - | - |
Investment purchases | -1.35 Million | -96 Million | -393.65 Million | -29.81 Million | -119.28 Million | -152.58 Million |
Sales/Maturities of investments | - | 111.45 Million | 401.86 Million | 96.81 Million | 93.42 Million | 91.96 Million |
Other Investing Activities | -59 Thousand | -2.11 Million | -6.86 Million | -6.47 Million | -336 Thousand | -5000.00 |
Financing Cash Flow | 12.39 Million | 16.63 Million | 86.76 Million | -48.63 Million | 48.28 Million | -22.49 Million |
Debt repayment | -335.42 Million | -9.56 Million | -341.4 Million | -34.24 Million | -301.85 Million | -31.42 Million |
Dividends payments | -319.47 Million | - | -260.4 Million | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -3.55 Million | 26.2 Million | 5.77 Million | -14.39 Million | 6.83 Million | 8.93 Million |
Accounts receivables | -173.78 Million | - | - | - | - | - |
Accounts payables | 130.67 Million | - | - | - | - | - |
Inventory | 2.81 Million | 1.37 Million | -7.12 Million | -1.18 Million | -3.47 Million | -9.34 Million |
Other working capital | 33.95 Million | - | - | - | - | - |
Cash at beginning of period | 1.84 Billion | 1.71 Billion | 1.3 Billion | 1.63 Billion | 1.51 Billion | 1.47 Billion |
Cash at end of period | 1.92 Billion | 1.84 Billion | 1.71 Billion | 1.71 Billion | 1.63 Billion | 1.51 Billion |
Capital Expenditure | -14.21 Million | -28.33 Million | -56.97 Million | -22.26 Million | -11.6 Million | -5.19 Million |
Effect of forex changes on cash | -461 Thousand | 2.93 Million | -2.03 Million | 396 Thousand | 1.27 Million | -4.51 Million |
Net cash flow / Change in cash | 77.4 Million | 129.03 Million | 419.22 Million | 81.25 Million | 127.58 Million | 39.47 Million |
Free Cash Flow | 93.19 Million | 138.75 Million | 468.48 Million | 65.4 Million | 167.86 Million | 119.49 Million |
PLT
PVCT
BIOVIC-B
URHG
GXH
BEWFF